150 related articles for article (PubMed ID: 30650407)
1. Probable Etoricoxib-Induced Severe Thrombocytopenia: A Case Report.
Recinella G; De Marchi A; Pirazzoli E; Bianchi G
Med Princ Pract; 2019; 28(4):387-389. PubMed ID: 30650407
[TBL] [Abstract][Full Text] [Related]
2. Etoricoxib-induced toxic epidermal necrolysis: A fatal case report.
Roy SS; Mukherjee S; Era N; Mukherjee M
Indian J Pharmacol; 2018; 50(3):139-142. PubMed ID: 30166751
[TBL] [Abstract][Full Text] [Related]
3. Etoricoxib-induced fixed drug eruption: Report of seven cases.
Martínez Antón MD; Galán Gimeno C; Sánchez de Vicente J; Jáuregui Presa I; Gamboa Setién PM
Contact Dermatitis; 2021 Mar; 84(3):192-195. PubMed ID: 32666601
[TBL] [Abstract][Full Text] [Related]
4. Bullous Fixed Drug Eruption Caused by Etoricoxib Confirmed by Patch Testing.
Carneiro-Leão L; Rodrigues Cernadas J
J Allergy Clin Immunol Pract; 2019; 7(5):1629-1630. PubMed ID: 30777670
[No Abstract] [Full Text] [Related]
5. Severe thrombocytopenia possibly associated with TMP/SMX therapy.
Yamreudeewong W; Fosnocht BJ; Weixelman JM
Ann Pharmacother; 2002 Jan; 36(1):78-82. PubMed ID: 11816265
[TBL] [Abstract][Full Text] [Related]
6. The first example of a patient with etoricoxib-induced immune hemolytic anemia.
Mayer B; Genth R; Dehner R; Salama A
Transfusion; 2013 May; 53(5):1033-6. PubMed ID: 22882551
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-induced thrombocytopenia: a case proven with rechallenge.
Marraffa J; Guharoy R; Duggan D; Rose F; Nazeer S
Pharmacotherapy; 2003 Sep; 23(9):1195-8. PubMed ID: 14524652
[TBL] [Abstract][Full Text] [Related]
8. Fixed drug eruption by etoricoxib confirmed by patch test.
Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
Ruggero MA; Abdelghany O; Topal JE
Pharmacotherapy; 2012 Nov; 32(11):e321-5. PubMed ID: 23065779
[TBL] [Abstract][Full Text] [Related]
11. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Brattwall M; Turan I; Jakobsson J
Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
[TBL] [Abstract][Full Text] [Related]
12. Eptifibatide-associated acute, profound thrombocytopenia.
Coons JC; Barcelona RA; Freedy T; Hagerty MF
Ann Pharmacother; 2005 Feb; 39(2):368-72. PubMed ID: 15644467
[TBL] [Abstract][Full Text] [Related]
13. Severe thrombocytopenia associated with alatrofloxacin.
Gales BJ; Sulak LB
Ann Pharmacother; 2000 Mar; 34(3):330-4. PubMed ID: 10917380
[TBL] [Abstract][Full Text] [Related]
14. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.
Russell KN; Schnabel JG; Rochetto RP; Tanner MC
Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261
[TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report.
Moore J; Baer MR; Grover BE; Aster RH; Millstein LS
Cureus; 2020 Sep; 12(9):e10507. PubMed ID: 33094048
[TBL] [Abstract][Full Text] [Related]
16. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
17. Acute profound thrombocytopenia following abciximab therapy.
Bishara AI; Hagmeyer KO
Ann Pharmacother; 2000; 34(7-8):924-30. PubMed ID: 10928405
[TBL] [Abstract][Full Text] [Related]
18. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
Nguyen VD; Tourigny JF; Roy R; Brouillette D
Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
[TBL] [Abstract][Full Text] [Related]
19. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.
Greenwald M; Peloso PM; Mandel D; Soto O; Mehta A; Frontera N; Boice JA; Zhan XJ; Curtis SP
Curr Med Res Opin; 2011 Oct; 27(10):2033-42. PubMed ID: 21905970
[TBL] [Abstract][Full Text] [Related]
20. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
Calistru AM; Cunha AP; Nogueira A; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
